01273 077222|info@expertsinskinandhair.co.uk

Experts in Skin & Hair
Book

Dr Paul Farrant: publications

  1. 46.Meah N, Li J, Wall D, ...., Farrant P, ...., Sinclair R. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024. J Eur Acad Dermatol Venereol. 2026 Feb;40(2):210-223. doi: 10.1111/jdv.20833. Epub 2025 Jul 23. PMID: 40698981; PMCID: PMC12843854.
  2. 45.Harries MJ, Ahmed A, Ascott A, ...., Farrant P, ...., Constantin AM. British Association of Dermatologists living guideline for managing people with alopecia areata 2025. Br J Dermatol. 2026 Jan 27;194(2):e56-e73. doi: 10.1093/bjd/ljaf452. PMID: 41234147.
  3. 44.Harries MJ, Ascott A, Asfour L, Farrant P, ...., Constantin AM; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists living guideline for managing people with alopecia areata 2024. Br J Dermatol. 2025 Jan 24;192(2):190-205.
  4. 43.Piliang M, Soung J, King B, ...., Farrant P, ...., Lejeune A. Efficacy and safety of the oral JAK3/TEC family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase 2b/3 and long-term phase 3 clinical studies in alopecia areata. Br J Dermatol. 2025 Jan 24;192(2):215-227
  5. 42.Takwale A, Arthur E, Pearce J, Farrant P, ...., Harries M. A practical guide to the standardisation of hair loss photography for clinicians. Clin Exp Dermatol. 2024 Aug 17:llae341. doi: 10.1093/ced/llae341. Epub ahead of print. PMID: 39152787.
  6. 41.ASAMI Consensus Survey Study Group; Moussa A, Bennett M, Wall D, ...., Farrant P, ...., Sinclair R. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity. JAMA Dermatol. 2024 Mar 1;160(3):341-350. doi: 10.1001/jamadermatol.2023.5869. PMID: 38324292.
  7. 40.Galván SV, Piraccini BM, Reygagne P, Farrant P, ...., Blume-Peytavi U. A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization. Eur J Dermatol. 2023 Dec 1;33(6):648-656. doi: 10.1684/ejd.2023.4578. PMID: 38465546.
  8. 39.Vañó-Galván S, Blume-Peytavi U, Farrant P, ...., Piraccini BM. Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries. Dermatol Ther (Heidelb). 2023 Dec;13(12):3121-3135. doi: 10.1007/s13555-023-01057-0. Epub 2023 Oct 27. PMID: 37889388; PMCID: PMC10689682.
  9. 38.Wright WA, Kamp E, Musbahi E, ...., Farrant P. Focal alopecia associated with a plaque. Clin Exp Dermatol. 2023 Mar 1;48(3):272-275. doi: 10.1093/ced/llac030. PMID: 36763693.
  10. 37.Basmanav FB, Cesarato N, Kumar S, ...., Farrant P, ...., Betz RC. Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals. JAMA Dermatol. 2022 Nov 1;158(11):1245-1253. doi: 10.1001/jamadermatol.2022.2319. PMID: 36044230; PMCID: PMC9434486.
  11. 36.Cummins DM, Marshall C, Asfour L, ...., Farrant P, ...., Harries M. Frontal fibrosing alopecia: survey of severity assessment methods in routine clinical practice and validation of the International Frontal Fibrosing Alopecia Cooperative Group measurement guidance. Clin Exp Dermatol. 2022 May;47(5):903-909. doi: 10.1111/ced.15035. Epub 2022 Jan 20. PMID: 34826169.
  12. 35.Meah N, Wall D, York K, ...., Farrant P, ...., Sinclair RD. The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata. J Am Acad Dermatol. 2021 Jun;84(6):1594-1601. doi: 10.1016/j.jaad.2020.09.028. Epub 2020 Sep 12. PMID: 32926985.
  13. 34.Wall D, Meah N, York K, ...., Farrant P, ...., Sinclair R. A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS). JAMA Dermatol. 2021 Apr 1;157(4):1-11. doi: 10.1001/jamadermatol.2020.5839. PMID: 33656556.
  14. 33.McSweeney SM, Christou EAA, Dand N, ...., Farrant P, ...., Tziotzios C. Frontal fibrosing alopecia: a descriptive cross- sectional study of 711 cases in female patients from the UK. Br J Dermatol. 2020 Dec;183(6):1136-1138. doi: 10.1111/bjd.19399. Epub 2020 Sep 10. PMID: 32652611.
  15. 32.Meah N, Wall D, York K, ...., Farrant P, ...., Sinclair R. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020 Jul;83(1):123-130. doi: 10.1016/j.jaad.2020.03.004. Epub 2020 Mar 9. PMID: 32165196.
  16. 31.Tziotzios C, Petridis C, Dand N, ...., Farrant P, ...., McGrath JA. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02. Nat Commun. 2019 Mar 8;10(1):1150. doi: 10.1038/s41467-019-09117-w. PMID: 30850646; PMCID: PMC6408457.
  17. 30.Macbeth A, Tomlinson J, Messenger A, ...., Farrant P, ...., Harries M. Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership. Br J Dermatol. 2018 Feb;178(2):535-540. doi: 10.1111/bjd.15810. Epub 2018 Jan 16. PMID: 28714061.
  18. 29.Debroy Kidambi A, Dobson K, Holmes S, ...., Farrant P, ...., Messenger AG. Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens. Br J Dermatol. 2017 Jul;177(1):260-261. doi: 10.1111/bjd.15311. Epub 2017 May 23. PMID: 28112792.
  19. 28.Macbeth AE, Tomlinson J, Messenger AG, ...., Farrant P, ...., Harries MJ. Establishing and prioritizing research questions for the treatment of alopecia areata: the Alopecia Areata Priority Setting Partnership. Br J Dermatol. 2017 May;176(5):1316-1320. doi: 10.1111/bjd.15099. Epub 2017 Apr 16. PMID: 27696375.
  20. 27.Basmanav FB, Cau L, Tafazzoli A, ...., Farrant P, ...., Betz RC. Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome. Am J Hum Genet. 2016 Dec 1;99(6):1292-1304. doi: 10.1016/j.ajhg.2016.10.004. Epub 2016 Nov 17. PMID: 27866708; PMCID: PMC5142115.
  21. 26.Arujuna NR, Topham EJ, Atkinson LR, ...., Farrant PB. Bimatoprost solution 0·03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis. Br J Dermatol. 2016 Jun;174(6):1416-7. doi: 10.1111/bjd.14472. Epub 2016 Mar 1. PMID: 26873623.
  22. 25.Harries MJ, Wong S, Farrant P. Frontal Fibrosing Alopecia and Increased Scalp Sweating: Is Neurogenic Inflammation the Common Link? Skin Appendage Disord. 2016 May;1(4):179-84. doi: 10.1159/000444758. Epub 2016 Mar 22. PMID: 27386462; PMCID: PMC4908440.
  23. 24.Mahendran P, George SM, Farrant PB. Trichorrhexis nodosa: a distinctive presentation after tumour necrosis factor-α inhibitor therapy. Clin Exp Dermatol. 2016 Apr;41(3):313-4. doi: 10.1111/ced.12727. Epub 2015 Jul 24. PMID: 26206274.
  24. 23.George SM, Taylor MR, Farrant PB. Psoriatic alopecia. Clin Exp Dermatol. 2015 Oct;40(7):717-21. doi: 10.1111/ced.12715. Epub 2015 Jul 23. PMID: 26202646.
  25. 22.Champagne C, Taylor M, Farrant P. Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure. Clin Exp Dermatol. 2015 Jul;40(5):589-90. doi: 10.1111/ced.12596. Epub 2015 Mar 18. PMID: 25787155.
  26. 21.Ormerod AD, Thomas KS, Craig FE, ....Farrant P…., Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. Erratum in: BMJ. 2017 Mar 21;356:j1462. doi: 10.1136/bmj.j1462. PMID: 26071094; PMCID: PMC4469977.
  27. 20.George SM, Atkinson LR, Farrant PB, Shergill BS. Botulinum toxin for focal hyperhidrosis of the face. Br J Dermatol. 2014 Jan;170(1):211-3. doi: 10.1111/bjd.12568. PMID: 23909999.
  28. 19.Campbell LF, Farmery L, George SM, Farrant PB. Canine olfactory detection of malignant melanoma. BMJ Case Rep. 2013 Oct 14;2013:bcr2013008566. doi: 10.1136/bcr-2013-008566. PMID: 24127369; PMCID: PMC3822260.
  29. 18.Patel KV, Farrant P, Sanderson JD, Irving PM. Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jul;19(8):1753-63. doi: 10.1097/MIB.0b013e31828132de. PMID: 23624889.
  30. 17.Messenger AG, McKillop J, Farrant P, ...., Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012 May;166(5):916-26. doi: 10.1111/j.1365-2133.2012.10955.x. PMID: 22524397.
  31. 16.Craig FF, Thomas KS, Mitchell EJ, ...., Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials. 2012 Apr 28;13:51. doi: 10.1186/1745-6215-13-51. PMID: 22540770; PMCID: PMC3423010.
  32. 15.George SM, Morrison IK, Farrant PB, Coburn PR. Intravenous glomus tumour of the upper arm. BMJ Case Rep. 2012 Jan 18;2012:bcr1120115152. doi: 10.1136/bcr.11.2011.5152. PMID: 22665877; PMCID: PMC3263121.
  33. 14.Amin AN, DeGiovanni CV, Farrant PB, ...., Woollons A. Photodynamic therapy for the treatment of keratolytic winter erythema. Clin Exp Dermatol. 2011 Aug;36(6):668-9. doi: 10.1111/j.1365-2230.2010.03927.x. Epub 2010 Aug 25. PMID: 20738319.
  34. 13.Chattopadhyay M, Farrant P, Higgins E, ...., Calonje E. A nodular lesion of the toe. Superficial acral fibromyxoma (SAF). Clin Exp Dermatol. 2010 Oct;35(7):807-9. doi: 10.1111/j.1365-2230.2010.03789.x. PMID: 20831611.
  35. 12.Cohen SN, Farrant PB, Taibjee SM. Assessing the assessments: U.K. dermatology trainees' views of the workplace assessment tools. Br J Dermatol. 2009 Jul;161(1):34-9. doi: 10.1111/j.1365-2133.2009.09097.x. Epub 2009 Mar 26. PMID: 19416267.
  36. 11.Farrant P, Abu-Nab Z, Hextall J. Tender erythematous nodules on the lower limb. Clin Exp Dermatol. 2009 Jun;34(4):549-51. doi: 10.1111/j.1365-2230.2008.02711.x. PMID: 19522989.
  37. 10.Farrant P, Degiovanni C, Emerson R. Familial yellow papules. Clin Exp Dermatol. 2009 Apr;34(3):435-6. doi: 10.1111/j.1365-2230.2008.02702.x. PMID: 19309381.
  38. 9.Degiovanni CV, Farrant PB, Howell S, ...., Woollons A. Keratolytic winter erythema with facial involvement: a novel presentation. Clin Exp Dermatol. 2009 Mar;34(2):206-8. doi: 10.1111/j.1365-2230.2008.02825.x. Epub 2008 Nov 6. PMID: 19018790.
  39. 8.Farrant P, Darley C, Carmichael A. Is erythromycin an effective treatment for chronic bullous disease of childhood? A national survey of members of the British Society for Paediatric Dermatology. Pediatr Dermatol. 2008 Jul- Aug;25(4):479-82. doi: 10.1111/j.1525-1470.2008.00741.x. PMID: 18789096.
  40. 7.Brown VL, Farrant PB, Turner RJ, ...., Burge SM. Multiple aggressive squamous skin cancers in association with nonbullous congenital ichthyosiform erythroderma. Br J Dermatol. 2008 May;158(5):1125-8. doi: 10.1111/j.1365-2133.2008.08463.x. Epub 2008 Feb 15. PMID: 18279460.
  41. 6.Farrant P, Cohen SN, Burge SM. Attributes of an effective trainer: implications of the views of UK dermatology trainees. Br J Dermatol. 2008 Mar;158(3):544-8. doi: 10.1111/j.1365-2133.2007.08394.x. Epub 2008 Jan 17. PMID: 18205874.
  42. 5.Farrant PB, Emerson R. Letter: hyfrecation and curettage as a treatment for fibrofolliculomas in Birt-Hogg-Dube syndrome. Dermatol Surg. 2007 Oct;33(10):1287-8. doi: 10.1111/j.1524-4725.2007.33270.x. PMID: 17903168.
  43. 4.Farrant P, Creamer D, Fuller C. Extensive cutaneous fibrosis and ulceration caused by methadone injection. Clin Exp Dermatol. 2005 Jan;30(1):87-8. doi: 10.1111/j.1365-2230.2004.01662.x. PMID: 15663513.
  44. 3.Farrant P, McGibbon D. Hand graft or hard luck. Clin Exp Dermatol. 2004 Sep;29(5):569-70. doi: 10.1111/j.1365-2230.2004.01617.x. PMID: 15347359.
  45. 2.Farrant P, Higgins E. A granulomatous response to tribal medicine as a feature of the immune reconstitution syndrome. Clin Exp Dermatol. 2004 Jul;29(4):366-8. doi: 10.1111/j.1365-2230.2004.01532.x. PMID: 15245531.
  46. 1.Farrant PB, Mortimer PS, Gore M. Scleroderma and the taxanes. Is there really a link? Clin Exp Dermatol. 2004 Jul;29(4):360-2. doi: 10.1111/j.1365-2230.2004.01519.x. PMID: 15245529.

← Back to Dr Paul Farrant's profile